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Abstract
Background: Antibodies are critical tools in many avenues of biological research. Though antibodies can be produced in the
research laboratory setting, most research labs working with vertebrates avail themselves of the wide array of commercially
available reagents. By contrast, few such reagents are available for work with model organisms.
Methodology/Principal Findings: We report the production of monoclonal antibodies directed against a wide range of
proteins that label specific subcellular and cellular components, and macromolecular complexes. Antibodies were made to
synaptobrevin (SNB-1), a component of synaptic vesicles; to Rim (UNC-10), a protein localized to synaptic active zones; to
transforming acidic coiled-coil protein (TAC-1), a component of centrosomes; to CENP-C (HCP-4), which in worms labels the
entire length of their holocentric chromosomes; to ORC2 (ORC-2), a subunit of the DNA origin replication complex; to the
nucleolar phosphoprotein NOPP140 (DAO-5); to the nuclear envelope protein lamin (LMN-1); to EHD1 (RME-1) a marker for
recycling endosomes; to caveolin (CAV-1), a marker for caveolae; to the cytochrome P450 (CYP-33E1), a resident of the
endoplasmic reticulum; to b-1,3-glucuronyltransferase (SQV-8) that labels the Golgi; to a chaperonin (HSP-60) targeted to
mitochondria; to LAMP (LMP-1), a resident protein of lysosomes; to the alpha subunit of the 20S subcomplex (PAS-7) of the
26S proteasome; to dynamin (DYN-1) and to the a-subunit of the adaptor complex 2 (APA-2) as markers for sites of clathrin-
mediated endocytosis; to the MAGUK, protein disks large (DLG-1) and cadherin (HMR-1), both of which label adherens
junctions; to a cytoskeletal linker of the ezrin-radixin-moesin family (ERM-1), which localized to apical membranes; to an
ERBIN family protein (LET-413) which localizes to the basolateral membrane of epithelial cells and to an adhesion molecule
(SAX-7) which localizes to the plasma membrane at cell-cell contacts. In addition to working in whole mount
immunocytochemistry, most of these antibodies work on western blots and thus should be of use for biochemical
fractionation studies.
Conclusions/Significance: We have produced a set of monoclonal antibodies to subcellular components of the nematode
C. elegans for the research community. These reagents are being made available through the Developmental Studies
Hybridoma Bank (DSHB).
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Introduction
Antibodies are critical tools for the study of cell and
developmental biology in metazoans. They are widely used for
the detection and characterization of cellular components in situ, in
cell culture, and in the test tube. Although other means to detect
and study proteins in vivo have been developed over the last decade
including the extensive use of green fluorescent protein (GFP) and
GFP-derivatives, antibodies remain exceedingly valuable reagents
for modern biology research.
Both monoclonal and polyclonal antibodies can be made using
different methodologies. Polyclonal sera have the advantage of
typically being of higher affinity, but they are non-renewable
resources. Monoclonal antibodies expressed by antibody express-
ing hybridomas are generally of more modest affinity, but higher
specificity since each monoclonal recognizes only a single epitope.
The greatest value of monoclonal reagents is that they can be
produced in limitless quantities. Another is that they can be used
in conjunction with polyclonal antibodies raised in other species
for double labeling.
Though monoclonal and polyclonal antibodies can be produced
in the research laboratory setting, most research labs working with
vertebrates avail themselves of the wide array of both monoclonal
and polyclonal antibodies available for purchase from numerous
companies. By contrast, few such commercial reagents are
available for work with model organisms such as C. elegans. Since
most C. elegans proteins are significantly divergent from their
vertebrate orthologs few commercial reagents are useful for the
study of C. elegans. Furthermore, only a very modest number of
immunological reagents have been made to C. elegans cellular
components. Most of these antibody reagents are polyclonals
made by individual investigators. As a result, many are not widely
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available (either because the sera is not being distributed or has all
been used) or are only available in limited quantities.
Previously a number of monoclonals have been developed
against specific C. elegans components. A few individual scientists
have expended the effort to develop monoclonals against specific
reagents of use in their research (e.g. a-PAR-3 and a-CHA-1;
[1,2]). Another approach by researchers in an attempt to obtain
monoclonal antibodies to one organism has been to use the entire
organism or cellular parts (e.g. head, ovary extracts, muscle) of the
organism as an immunogen. This approach has been taken for the
organism, Ascaris suum [3], Macrostomum sp. [4], Aspergillus [5],
Drosophila [6], and C. elegans [7,8,9,10,11]. A difficulty with this
approach is the enormous amount of time and expense it takes to
characterize the group of monoclonal antibodies, since the antigen
recognized by the monoclonal is unknown without further
characterization.
In this study, we describe the creation and characterization of
mouse monoclonal antibodies against a variety of nematode
proteins with the aim of providing a set of tools that can be used by
the scientific community to label specific cellular and subcellular
compartments in C. elegans. The targets chosen include common
organelles (e.g. endoplasmic reticulum, endosomes), specialized
organelles (e.g. synaptic vesicles), subcellular domains common to
all cells (e.g. centrosomes, nuclear membrane), and macromolec-
ular complexes (e.g. proteasomes, replication origin complex).
These reagents are being made available to the scientific
community through the Developmental Studies Hybridoma Bank
(DSHB), which provides monoclonal reagents in the form of cell
lines and cell products at modest cost.
Results
To develop monoclonal reagents that detect distinct subcel-
lular compartments and structures for C. elegans we opted
primarily to create monoclonal antibody lines against protein
that had previously been documented to be detectable at
endogenous levels in wild type C. elegans using a polyclonal sera.
Below we describe each monoclonal reagent that we created
that performed adequately in western blot and/or whole mount
immunocytochemistry on wild type animals. Table 1 provides a
summary of these antibodies. A list of other antigens to which
we developed monoclonal antibodies, which failed in our tests to
detect endogenous protein is provided in the supplementary
methods.
SNB-1
snb-1 encodes a neuronal v-SNARE synaptobrevin (VAMP)
which is localized primarily to synaptic vesicles in C. elegans [12].
Monoclonal antibodies against C. elegans SNB-1, without the
transmembrane region were made by immunizing mice with a
Table 1. Monoclonal antibodies described in this study.
Gene mAb name(s) Subcellular localization Westerns Immuno-histochemistry
SNB-1 SB1 synaptic vesicles +++ +++
UNC-10 RIM RIM2 synaptic active zones 2 +++1
DLG-1 DLG1 adherens junctions +++ +++
HMR-1 HMR1 adherens junctions 2 +++
ERM-1 ERM1 Apical membranes +++ +++
LET-413 LET413 basolateral membranes +++ +++
SAX-7 SAX7 plasma membrane at cell-cell contacts +++ 2 +++
HCP-4 HCP4 centromeres + +++
LMN-1 LMN1 nuclear membranes +++ +++
DAO-5 DAO5 nucleosomes ++3 +++
ORC-2 ORC2 replication origins ++ +++
PAS-7 PAS7 26S proteasome +++ ++
TAC-1 TAC1 Centrosomes +++ +++
HSP-60 HSP60 mitochondria +++ +++
CAV-1 CAV1 caveolae4 +++ +++
CYP-33a CYP33a ER + +++
SQV-8 SQV8 Golgi +++ +++
LMP-1 LMP1 lysosomes +++ +++5
RME-1 RME1 recycling endosomes +++ +++
DYN-1 DYN1 sites of clathrin-mediated endocytosis +++ +++
APA-2 APA2 clathrin adaptor + ++
------- his6 his6 tag +++ +++
+++= easily detected ++=detected +=detectable 2=not detected.
footnotes. See Text for additional details.
1RIM, but not RIM2 also detects staining of the pharynx that does not disappear in unc-10 mutants.
2SAX7 monoclonal detects only a 60 kD proteolytic fragment.
3multiple forms seen on Westerns which may represent multimers.
4It is unclear if C. elegans has caveolae as traditionally defined.
5some nervous system staining which remains present in lmp-1 null mutants.
doi:10.1371/journal.pone.0010161.t001
C. elegans Monoclonals
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His6-tagged fusion protein to amino acids 1-86 which had
previously been used for the generation of rabbit polyclonal
antibodies [12]. Three stable hybridoma cell lines (2E6, 5D1,
and 5G1) were produced and all were of the isotype IgG1. All
three of the monoclonal antibodies were examined on whole
mount animals and found to have an immunostaining pattern
similar to what had previously been reported with a polyclonal
antibody [12]; bright signals in the nerve ring, dorsal and
ventral nerve cords (Figure 1A). Western blots of wild type and
mutant animals [12], snb-1(md247), showed that the monoclonal
antibody was specific Figure 2A. A 16 kDa band was seen in
wild type lysate, and in snb-1(md247) lysates this band shifted to
19 kDa and was reduced in intensity (data not shown) as has
previously been reported [13]. Of the three hybridoma cell
lines, 5D1 was re-named SB1 and was sent to the Develop-
mental Studies Hybridoma Bank (DHSB). This SB1 monoclonal
antibody has been previously used on westerns to detect SNB-1
protein that had been immunoprecipitated by the polyclonal
antibody from soluble extracts of C. elegans [14]. Finally, the
epitope of this monoclonal (PRPSNKRLQQ) had been deduced
by others [15].
UNC-10
unc-10 encodes a homolog of the vertebrate proteins RIM1 and
RIM2 which is specifically localized to the periphery of the active
zone in neurons in C. elegans [16,17]. The C. elegans UNC-10
monoclonal antibodies were made by immunizing mice with a
His6-tagged fusion protein to the N-terminus zinc finger domain,
amino acids 1–144 which had previously been used for the
generation of rabbit polyclonal antibodies [17]. Seven stable
hybridoma cell lines (1D8, 1H4, 2E11, 2F3, 3H9, 4A5, and 4E11)
were produced of the isotype IgG1, except for 2F3, which was of
the isotype IgG2a. All seven monoclonal antibodies immuno-
stained whole mount animals with a pattern that had previously
been reported with the polyclonal antibody [17]: it detects a dense
network of puncta in the nerve ring, dorsal and ventral nerve cords
(Figure 1B1 & C1 and data not shown). Immunostaining was
absent in unc-10(md1117) with the monoclonal antibodies 2E11
and 4E11 (Figure 1C1 and C2 and data not shown). A similar
pattern of immunostaining was seen with the monoclonal
antibody, 4A5, except some faint staining was seen in the pharynx
in the mutant strain (Figure 1B2). Western blots of extracts of
transgenic animals carrying the N-terminal domain of UNC-10
Figure 1. Whole mount immunocytochemistry of C. elegans larvae using monoclonal antibodies. A) The head of an adult animal shows
the synaptic rich regions of the nervous system detected by the anti-synaptobrevin SB1 antibody. B1) Head of an L4 animal showing punctate
synaptic staining of the nervous system detected by the RIM antibody. Note that some pharyngeal staining is also observed. B2) Head of an L4 animal
showing loss of the punctate nervous system staining, but not the pharyngeal staining, in unc-10(md1117). C1) Head of an L4 animal showing
punctate synaptic staining in the nervous system detected by the RIM2 antibody. C2) Head of an L4 animal showing loss of the punctate nervous
system staining in unc-10(md1117). D) Head of an adult animal showing anti-SAX-7 staining of the neurons in the nerve ring ganglia and pharynx. E)
An L1 animal showing staining of the nervous system with the anti-LMN-1 antibody. F) L4 animal showing punctate cytosolic anti-PAS-7 staining. G)
An L2/L3 animal showing staining of the nervous system with the anti DYN-1 antibody. H) L1 (top) and L2 animals showing the staining of the
intestine with the anti-LMP-1 antibody. I) an egg and L1 animal showing the APA-2 staining. APA-2 is particularly strong in the seam cells in L1. Scale
bar = 20 mm.
doi:10.1371/journal.pone.0010161.g001
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documented that the antibody will detect the zinc finger domain
on westerns [14], but the antibody has not been reliable in
detecting native UNC-10 perhaps due to difficulties in transferring
the protein to membranes (data not shown). The 4A5 and 4E11
hybridoma cell lines, re-named RIM and RIM2, have been
submitted to DHSB in Iowa for distribution to the scientific
community.
DLG-1
dlg-1 encodes a C. elegans homolog of the membrane-associated
guanylate kinase (MAGUK) family of scaffolding proteins that
includes drosophila disks large protein, after which dlg-1 is named. In C.
elegans, DLG-1 is primarily associated with the adherens junctions
[18,19]. The monoclonal antibody against C. elegans DLG-1 was
made by immunizing mice with a His6-tagged fusion protein
encompassing amino acids 204–593 (PDZ domain 1–3). This
construct contained the same DLG-1 coding fragment that had
previously been reported for the generation of rabbit and rat
polyclonal antibodies [19]. One stable hybridoma cell line, 5E2, was
produced and isotyped as IgG1. On whole mount immunostain of
wild type C. elegans, an immunostain pattern was seen that had
previously been reported with the polyclonal antibody and DLG-1-
GFP transgenes [18,19,20,21]: adherens junctions of hypodermis,
gut, and pharynx (Figure 3A and data not shown). Analysis of the
monoclonal on western blots of wild type animal lysates showed that
the 5E2 monoclonal antibody recognized an 107 kDa protein band
(Figure 2B). 5E2, re-named DLG1, has been submitted to the DHSB.
HMR-1
hmr-1 encodes a member of the classical cadherin family of cell
adhesion molecules. hmr-1 is expressed in many tissues and timed
during development; among other places it is highly expressed in
apical junctions of hypodermal cells during embryonic develop-
ment and later additionally becomes localized to the apical
margins of the intestine and pharynx [22,23,24]. The monoclonal
antibody against C. elegans HMR-1 was made by immunizing mice
with a His6-tagged fusion protein encompassing amino acids:
1099–1223. Previously, a polyclonal antibody had been reported
in the literature to be made from fourteen amino acids (HMR-1a
isotype amino acids: 1196–1209 of the C-terminus of HMR-1
[23]. Two stable hybridoma cell lines, 8H10 and 1A7, were
produced. The 8H10 monoclonal was the isotype IgM and the
1A7 monoclonal was a mixed isotype of IgG1+IgG2a+IgM. On
whole mount immunostain of wild type animals, an immunostain
pattern was seen that had previously been reported in the
literature for the polyclonal antibody and the GFP-fusion construct
[22,23,24]: nervous system, adherens junctions, blastomeres of
embryos, regions of contact between blastomeres, apical margins
of all hypodermal, intestinal, and pharyngeal cells (Figure 3B and
data not shown). With the 8H10 monoclonal antibody, no protein
bands could be detected on western blots (data not shown). With
the 1A7 monoclonal antibody a protein band of 130 kDa was
observed which is in agreement with the expected size of the
HMR-1 protein. Despite the potential benefits of the 1A7 line, the
8H10 monoclonal antibody, re-named HMR1, has been submit-
ted to the DHSB because it is of a single isotype.
ERM-1
erm-1 encodes a homolog of the ezrin-radixin-moesin (ERM)
family of cytoskeletal linker proteins. It localizes most prominently
to the apical membranes in the polarized alimentary tract, but is
also found on the apical cell cortex of many cells during
development [25]. Monoclonal antibodies against ERM-1 were
made by immunizing mice with a His6-tagged fusion protein
encompassing amino acids 209–563 of ERM-1. This fusion
protein is similar to the fusion protein, His6-ERM-1, amino acids
Figure 2. Western analysis using monoclonal antibodies. Western blots of whole wild type C. elegans extracts divided into three panels based
upon acrylamide concentration used for SDS-polyacrylamide gel electrophoresis. The antibody used is labeled above each blot fragment.
Approximately 20 to 30 mg of extract mixed staged extract was loaded in each lane. Molecular weight markers (BioRad Precision Plus Protein All Blue
Standards) from top to bottom 250,150, 100, 75, 50, 37, 25, 20, 15, 10 kDa. the contrast was lowered on the images of the CAV1 and DAO5 westerns
to permit visualization of multiple bands in a strong exposure.
doi:10.1371/journal.pone.0010161.g002
C. elegans Monoclonals
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207–563, that was used to make a previously reported polyclonal
antibody [25]. Four stable hybridoma cell lines (2H11, 5E2, 5G2,
and 7G2) were produced and were isotyped as IgG1. The ELISA
assays indicated that the monoclonal antibodies, 7G2 and 5G2,
were specific to the ERM-1 fusion protein and not to the His6-tag.
Whereas, the monoclonal antibodies, 2H11 and 5E2, reacted to
the His6-tag. On whole mount immunostaining of wild type, an
immunostain pattern was observed with the 7G2 and 5G2
monoclonal antibodies that resembled the pattern that had
previously been reported for an ERM-1 polyclonal antibody and
the GFP-ERM-1 reporters [25,26]: cell cortex of most cells, cell
cortex of contacting membranes in early stages, the apical cortex
of the pharyngeal-intestinal tract, hypodermal cells (Figure 3C and
data not shown). Immunoblots of C. elegans wild type lysates were
probed with the monoclonal antibodies. Both the 5G2 and 7G2
monoclonal antibodies recognized a single protein band of 72 kDa
on western blots (Figure 2C and data not shown), in good
agreement with the 65 kDa protein detected with polyclonal sera
[25]. Since the 7G2 antibody occasionally also detected a 10 kDa
band on westerns, the 5G2 monoclonal antibody, re-named
ERM1, was submitted to the DHSB.
LET-413
let-413 encodes a protein homolog of ERBIN, DENSIN-180 and
SCRIB, an epithelial basolateral membrane protein, in the LAP
family of proteins (contains leucine repeats and PDZ domains) [27].
Monoclonal antibodies were made against amino acids, 460–606.
This is similar to the domain that was used in making the polyclonal
antibody, amino acids 469–576 [28]. A polyclonal antibody was also
made to a 19 amino acid peptide, amino acids 592–606 [27]. Two
stable hybridoma cell lines, 4E3 and 5C12, were obtained and all
were the isotype IgM. On whole mount immunostains of wild type,
a staining pattern was observed that was similar to what had been
reported for the polyclonal antibodies and the GFP-construct
[27,28,29]: all cells of early embryos, epidermal cells, spermatheca,
pharynx, intestine, uterus, and nerve ring (Figure 3D and data not
shown). On western blots of wild type lysates, the 5C12 monoclonal
antibody detected protein bands of 76 kDa, as well as fainter bands
of 110 kDa and 200 kDa (Figure 2C). This size is in good agreement
with the predicted Mw of the LET-413 protein, 75 kDa, which was
recognized by the polyclonal antibodies [27]. The 5C12 monoclo-
nal antibody, re-named LET413, has been submitted to the
DHSB.
Figure 3. Whole mount immunocytochemistry of embryos using monoclonal antibodies. A) Pre-comma staged embryo showing anti-
DLG-1 staining in developing hypodermal cells. B) A three-fold embryo showing anti-HMR-1 staining of adherens junctions. C) A three-fold embryo
showing anti-ERM-1 staining in the apical junctions in the developing pharynx and intestine. D) A pre-comma embryo showing anti-LET-413 staining.
E) A one and half-staged embryo showing anti-HSP-60 staining. F) A ,40 cell embryo showing anti-CAV-1 staining. G) A pre-comma staged animal
showing anti-SQV-8 staining. H) A pre-comma staged embryo showing anti-RME-1 staining. I) An ,60 staged embryo showing anti-PAS-7 staining.
Scale Bar = 10 mm.
doi:10.1371/journal.pone.0010161.g003
C. elegans Monoclonals
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SAX-7
sax-7 encodes a homolog of the cell adhesion molecule L1/
CAM which localizes most prominently to sites of cell-cell contact
in the nervous system. Monoclonal antibodies were made against a
His6-tagged fusion to the SAX-7 cytoplasmic domain, amino acids
1051–1144. Four stable hybridoma cell lines (5.2.1, 5.2.6, 11.2.1,
and 11.2.3) were produced. Two of these monoclonals, 5.2.1 and
5.2.6, were isotyped as IgG2b and the other two monoclonals,
11.2.1 and 11.2.3, were isotyped as IgG1. On whole mount
immunostain of wild type C. elegans, an immunostain pattern was
observed that had previously been reported with the polyclonal
antibody which had been raised to a peptide on the C-terminus
cytoplasmic domain of SAX-7 [30,31,32]: plasma membrane at
sites of cell-cell contact throughout development, nervous system,
pharynx, hypodermis, body wall muscles, and germline (Figure 1D
and data not shown). Surprisingly, western blots of wild type
lysates showed that the monoclonal antibodies only recognized a
55 kDa protein band (Figure 2B). Immunoblots of C. elegans that
had been probed with the C-terminus SAX-7 peptide antibody
detected bands of 200 kDa, 185 kDa, 120 kDa, and 65 kDa
[30,31]. Another group that used the same polyclonal antibody
had detected protein bands of 160 kDa, 140 kDa, and 45 kDa on
westerns [33]. All three research groups proposed that the 45–
65 kDa protein band was the result of post-translational cleavage
of the long and short forms of the SAX-7 protein. The relative
abundance of these isoforms is unclear, though the 65 kD band
was by far the brightest signal in the only westerns that were shown
in full [30]. The larger forms appeared to be phosphorylated [30].
Thus, by western analysis, it appears that these monoclonal
antibodies only recognize the post-translational cleaved product
and not the short or long version of SAX-7. This could be because
the antibody recognizes the unphosphorylated version of an
epitope that is phosphorylated in vivo. The monoclonal line 11.2.1,
re-named SAX7, has been submitted to the DHSB.
HCP-4
hcp-4 encodes a homolog of CENP-C which localizes to the
centromere of chromosomes [34,35]. Due to the holocentric nature
of C. elegans chromosomes, their centromeres are more extended,
diffuse and discontinuous than typical centromeres [36,37]. The C.
elegans HCP-4 monoclonal antibodies were made by immunizing
mice with a His6-tagged fusion protein consisting of amino acids 9–
210. Three stable hybridoma cell lines (2E2, 3F4, 4B7) were
obtained and all were of the isotype IgM, except 4B7, which
appeared to be a mix of the isotypes, IgM, IgG1, and IgG2a. The
two monoclonals, 2E2 and 3F4, were used to examine the
immunostain pattern on whole mount embryos and were found
to stain in a pattern that was similar to what had been previously
reported for the polyclonal antibody [34,35]: nuclei and chromo-
somes (Figure 4A). The monoclonal antibodies against HCP-4 were
examined on western blots of wild type lysates of C. elegans and found
to recognize faint protein bands of 125 kDa and 80 kDa (Figure 2C).
Two protein bands, of 136 kDa and 70 kDa, had previously been
detected on westerns of wild type embryo extracts using an HCP-4
polyclonal antibody, and the 70 kDa band was determined to be
independent of the primary antibody [35]. 2E2 was re-named
HCP4 and has been submitted to the DHSB.
LMN-1
lmn-1 encodes a C. elegans homolog of nuclear lamin, a structural
nuclear envelope protein of the intermediate filament super family
that associates with the nuclear membrane [38]. A rabbit anti-LMN-1
polyclonal antibody directed against the rod and tail region of C. elegans
LMN-1 (amino acids 217–550), which recognized endogenous LMN-
1 has previously been reported [38,39]. Monoclonal antibodies were
made against a full length C. elegansHis6-tagged LMN-1 fusion protein
by immunizing mice. Four stable hybridoma cell lines (1B6, 2A7,
2G1, and 3D7) were produced and all were isotyped as IgG1. These
monoclonals were used to immunostain wild type whole mount
Figure 4. Whole mount immunocytochemistry of 2, 4 and 6 cell embryos using monoclonal antibodies. A) A two cell embryo showing
anti HCP-4 staining of chromosomes. B) A two cell embryo showing anti-LMN-1 staining of the nuclear envelope. C) A six cell embryo showing ORC-2
staining of chromosomes. D) A two cell embryo showing staining of anti-TAC-1 of centrosomes. E) Double labeling using the anti-TAC-1 monoclonal
and an anti-LMN-1 polyclonal antibody. F) A six cell embryo showing anti-DYN-1 staining. Scale Bar 10 mm.
doi:10.1371/journal.pone.0010161.g004
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animals and were found to label in a pattern that had been previously
reported for the polyclonal antibody [38,39,40]: nuclear periphery
(inner) and nuclear interior of most cells (Figure 1E and 4B). Western
blot analysis of wild type lysates probed with these monoclonal
antibodies revealed that they recognized a single protein band of
73 kDa (Figure 2C), in reasonable agreement with the 64–66 kDa
detected on westerns by polyclonal sera [38,39]. The 2G1monoclonal
antibody, re-named LMN1, has been submitted to the DHSB.
DAO-5
dao-5 encodes a homolog of the nucleolar phosphoprotein
Nopp140 [41]. Monoclonal antibodies against C. elegans DAO-5
were made by immunizing mice with a His6-tagged fusion protein
to amino acids 751–971. Six stable hybridoma cell lines (5E9,
7G8, 11A8, 13D5, 14C2, and 13H10) were produced and were
the isotype IgG1, except for 5E9 which was the isotype IgG2b, and
14C2 which was a mix of the isotypes IgG1 and IgG2b. In whole
mount immunocytochemistry, the single isotype monoclonals all
stained the nucleolus and nucleoplasm of somatic cells and germ
cells (Figure 5A1 and A2), which was similar to what was seen with
another nucleolus protein, nucleostemin [42]. Western blots of
wild type animal lysates revealed that the monoclonal antibodies
recognized multiple protein bands of 150 kDa, a dimer, and
60 kDa. With longer exposures, protein bands of 100 kDa, a
Figure 5. Immunocytochemistry of dissected gonad and intestines using monoclonal antibodies. A) Dissected gonad stained with DAPI
(A1) to visualize nuclei and immunostained with anti-DAO-5 antibodies (A2). B) Dissected intestine stained with DAPI (B1) to visualize nuclei (arrows)
and immunostained with anti CYP-33E1 antibodies (B2) and the merged view (B3). C) Dissected intestine stained with DAPI (C1) to visualize nuclei
(arrows) and immunostained with anti LMP-1 antibodies (C2) and the merged view (C3).
doi:10.1371/journal.pone.0010161.g005
C. elegans Monoclonals
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dimer, 36 kD, 20 kDa and 10 kDa were observed (Figure 2C).
The western analysis is consistent with prior reports that multiple
forms of this protein are often detected on westerns due to post-
translational modification, proteolysis, dimerization, trimerization
and alternative splicing [43,44,45,46,47]. The monoclonal
antibody 5E9, re-named DAO5, has been submitted to the
DHSB.
ORC-2
orc-2 encodes an evolutionarily conserved subunit of the origin
replication complex [48]. The monoclonal antibody against C.
elegans ORC-2 was made by immunizing mice with a full length
His6-tagged fusion protein, which was purified under denaturing
conditions. Three stable hybridoma cell lines (1H7, 4G8, and
4D4) were produced and all were isotyped as IgG1. All three of
the monoclonal antibodies were examined on whole mount
animals and found to immunostain the nucleus and what appears
to be the gonadal primordium (Figure 4C and data not shown).
Previously, it has been reported that the Drosophila and human
ORC2 proteins localize predominantly to the nucleus [49,50]. All
three monoclonal antibodies recognized a protein band of
49 kDa on western blots, the expected size of the ORC-2 protein
(Figure 2B). 4D4, renamed ORC2, has been submitted to the
DHSB.
PAS-7
pas-7 encodes the C. elegans ortholog of an evolutionarily
conserved subunit of the 26S proteasome subunit which is
involved in regulated protein degradation [51]. Monoclonal
antibodies were made against a purified His6-tagged PAS-7 full
length fusion protein. Six stable hybridoma cell lines (1A1, 2H4,
5B3, 5H2, 6C1, and 6C6) were produced and all were found to be
the isotype IgG1. All six monoclonal antibodies were examined on
lysates of C. elegans whole mounts and were found to label the
nucleus as well as the cytoplasm (Figure 1F and 3I) which was
similar to what has been reported for ataxin, ATX-3, which was
proposed to escort ubiquitylated substrates for proteasome
degradation, was found to be expressed in all developmental
stages and was found in the nucleus and cytoplasm [52,53]. The
6C1 and 5B3 antibodies were found to label multiple protein
bands on western blots of wild type extracts, while 1A1, 2H4, 5H2
and 6C6 were found to specifically label a single protein band of
28 kDa, consistent with the predicted size of PAS-7 (Figure 2A and
data not shown). The monoclonal antibody 1A1, re-named PAS7,
has been submitted to the DHSB.
TAC-1
tac-1 encodes a protein homologous to the transforming acid
coiled coil protein family which localizes to centrosomes in a cell
cycle dependent manner [54]. A polyclonal antibody directed
against full length TAC-1 recognized the endogenous protein in
early embryos [54]. A His6-tagged TAC-1 full length fusion
protein was used to immunize mice. Four stable hybridoma cell
lines (4.5.4, 4.5.6, 6.2.1, and 6.4.2) were produced, and all were
isotyped as IgG1. On whole mount immunostain of C. elegans
embryos, a pattern was seen which was similar to that reported for
both a polyclonal antibody and TAC-1::GFP fusions [54,55]:
staining at meiotic spindle poles, at centrosomes in one-cell
embryos and in the cytoplasm (Figure 4D and E). Western blots of
wild type extracts showed that the monoclonal antibodies
recognized primarily a 35 kDa protein band (Figure 2A). The
4.5.6 monoclonal antibody, re-named TAC1, was submitted to the
DHSB.
HSP-60
hsp-60 encodes a mitochondrial targeted heat shock protein.
Monoclonal antibodies were made against C. elegans His6-tagged
HSP-60a fusion protein, amino acids 1–547. Four stable
hybridoma cell lines (1G3, 1H12, 2H6, 2H12) were obtained.
All were isotyped as IgG1, except for 1G3 that was isotyped as
IgG2b. On whole mount immunostain of wild type C. elegans, an
immunostain pattern was observed similar to that previously
reported for mitochondrial staining [56,57]: signal around most
nuclei, speckles in mitotic germ cells, foci in the cytoplasm of
embryonic cells, and elongated tubular morphology in body wall
muscle (Figure 3E). Immunoblots of C. elegans wild type lysates
revealed that the monoclonals recognized a 65 kDa band in
agreement with the 60 kD size of the HSP-60a form of the protein
(Figure 2B). The monoclonal antibody, 1H12, re-named HSP60,
has been submitted to DHSB.
CAV-1
cav-1 encodes one of two caveolin homologs in C. elegans.
Vertebrate caveolins are the major proteins required for the
formation of plasma membrane invaginations called caveolae [58].
It remains unclear whether C. elegans has caveolae or if C. elegans cav
proteins localizes to them. However, both CAV-1 and CAV-2
localize to both the plasma membrane and to intracellular
structures referred to as CAV bodies [59,60]. Monoclonal
antibodies against C. elegans CAV-1 were made by immunizing
mice with a full-length His6-tagged fusion protein. A polyclonal
antibody raised against a C-terminal peptide of C. elegans CAV-1,
amino acids 219–232, has been previously reported to detect
endogenous CAV-1 [61]. Six stable hybridoma cell lines (1A3,
1A7, 1B4, 1F6, 1F12, and 3F1) were produced and were of the
isotype IgG1, except for 1B4 which was the isotype IgG3. All
seven monoclonal antibodies immunostained whole mount
animals with a pattern that had previously been reported with
the polyclonal antibody and GFP-fusion constructs [59,61,62]:
gonad germ cells, most embryonic cells, neurons, ventral nerve
cord, commissures and body wall muscles (Figure 3F and data not
shown). Western blot analysis of wild type lysates revealed that the
1F6 monoclonal antibody recognized two protein bands of 29 kDa
and 32 kDa (Figure 2A). The polyclonal antibody to the C-
terminus peptide of CAV-1 was reported to recognize a single
band of 31 kDa [61]. SDS-PAGE that had been done on the full-
length protein which had been expressed in COS-7 cells, revealed
a protein of 32–33 kDa [63]. The mammalian caveolin protein
has been found to exist in both a and b forms, which differ by
3 kD in size [64], analogous to what we observe with the IF6
monoclonal antibody. 1F6, re-named CAV1, has been submitted
to the DHSB.
CYP-33E1
cyp-33E1 encodes a cytochrome P450 family member involved
in the metabolism of isoniazid and likely localized to the
endoplasmic reticulum similarly to most P450 family members
[65]. A full length His6-tagged fusion protein of C. elegans CYP-
33E1 was used to immunize mice in the production of monoclonal
antibodies to CYP-33E1. Two stable hybridoma cell lines, 1D6
and 1G3, were produced and were isotyped as IgM. On whole
mount immunostain of wild type C. elegans (Figure 5B), a similar
pattern was seen that had previously been reported for rough
endoplasmic reticulum membrane proteins and endoplasmic
reticulum proteins [66]. Analysis of these monoclonals on western
blots of wild type animal lysates showed that they labeled a protein
band of 73 kDa (Figure 2B). Two faint band of 90 kDa and
110 kDa could also be detected. The predicted size of CYP-33E1
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is 58 kDa. The monoclonal antibody, 1G3, re-named CYP33E1
has been submitted to DHSB.
LMP-1
lmp-1 encodes a homolog of the lysosome associated membrane
protein family (LAMPs) and is highly expressed and localized to
lysosomal-like granules in the C. elegans intestine which can be
detected in wild type animals using an anti-LMP-1 polyclonal sera
[67]. The C. elegans monoclonal antibodies against LMP-1 were
made by immunizing mice with a His6-fusion protein consisting of
amino acids 18–160 of LMP-1. Two stable hybridoma cell lines,
2E2 and 2H11, were obtained and all were of the isotype IgG2b.
Both monoclonals were used to examine the immunostain pattern
on whole mount wild type and lmp-1(nr2045) animals [67]. In wild
type animals, the monoclonals were found to stain in a pattern that
was similar to what had been previously reported for the
polyclonal antibody and the GFP-construct [67,68]: subcellular
granules distributed throughout the early embryo, intestinal
granules from late embryo to adults, coelomocytes, lysosomes
(Figure 1H, 5C). In mutant animals, the staining pattern that was
seen in the wild type animals disappeared, but the immunostaining
of the nervous system remained and became more pronounced
(data not shown). This could be due to the monoclonal antibodies
cross-reacting to another LAMP protein such as UNC-46, which
has a conserved secondary structure with LMP-1 and is localized
at synapses and expressed in GABA neurons in C. elegans [69].
Western blots of wild type and mutant animals, nr2045, showed
that the two monoclonal antibodies against LMP-1 were specific.
A 37 kDa protein band was detected in wild type C. elegans lysate
but not in nr2045 mutant lysates (Figure 2B and data not shown).
The monoclonal antibody 2E2, re-named LMP1, has been
submitted to the DHSB
RME-1
rme-1 encodes an evolutionarily conserved protein specifically
associated with recycling endosomes [70]. An anti-RME-1
polyclonal serum detects RME-1 in a punctate pattern in multiple
tissues including the germline and intestine [70]. C. elegans
monoclonal antibodies against RME-1 were made by immunizing
mice with a His6-RME-1 fusion protein consisting of amino acids
333–575 of the RME-1d isoform. Nine stable hybridoma cell lines
(4E12,5G11,6B6,6D1,6F10, 7E2, 8D8, 10A5, and 10B10) were
obtained, and all were isotyped as IgG1. Two of the monoclonal
antibodies, 5G11 and 7E2, were examined on wild type whole
mount animals and were found to stain in a similar pattern that
had been reported for the polyclonal antibody and the GFP-
constructs [70]: germline cytoplasm, intestine, pharynx, associated
with the periphery of endocytic organelles (Figure 3H and data not
shown; also see [71]). A similar pattern of staining was seen with
the 4E12 and 6B6 monoclonal antibodies (Data not shown and B.
Grant unpublished data). Western blots of wild type lysates showed
that a protein band of 70 kDa was detected by the 5G11, 7E2,
6B6, and 4E12 monoclonals (Figure 2B and data not shown). The
other monoclonals labeled only very weakly (data not shown). The
monoclonal 5G11, re-named RME1, has been submitted to the
DHSB.
SQV-8
sqv-8 encodes a Golgi enzyme glucuronyl transferase that is a
homolog of three glucuronyl transferases, GlcAT-I, GlcAT-P, and
GlcAT-D that are involved in the synthesis of different
glycoconjugates [72,73]. The C. elegans SQV-8 monoclonal
antibodies were made by immunizing mice with a His6-tagged
SQV-8 fusion protein encompassing amino acids 150–349. This is
the same domain used to make SQV-8 polyclonal antibodies [59].
Two stable hybridoma cell lines, 5B3 and 3B7, were produced and
isotyped IgG1 (3B7) and IgG2b (5B3). On whole mount
immunostaining of wild type C. elegans (Figure 3G and data not
shown), all of the antibodies exhibited similar staining patterns,
labeling structures (probably Golgi) around the nucleus and also
stain the vulva [59]. On western blots of wild type C. elegans lysates,
a band of 75 kDa was recognized by the 5B3 monoclonal antibody
(Figure 2A). The predicted mass of SQV-8 is 41 kDa. The 5B3
monoclonal antibody, re-named SQV8, has been submitted to the
DHSB.
DYN-1
dyn-1 encodes a homolog of dynamin 1 which regulates clathrin
mediated endocytosis. Dynamin is concentrated at sites of clathrin
mediated endocytosis, where it binds to the neck of budding
clathrin coated pits. A polyclonal antibody directed against the C-
terminal half of the C. elegans DYN-1 protein detects the
endogenous protein in the nervous system [74]. Monoclonal
antibodies against C. elegans DYN-1 were made by immunizing
mice with a full length His6-tagged DYN-1 fusion protein
(generously provided by Z. Zhou and N. Lu; Baylor College of
Medicine). Five stable hybridoma cell lines (1A2, 2D6, 3H1, 5B1,
and 5C2) were produced and found to be the isotype, IgG2a,
except 5C2 which was the isotype IgG1. On whole mount
immunostain of wild type C. elegans, an immunostain pattern was
seen that had previously been reported with the polyclonal
antibody and GFP-fusion constructs [74,75,76,77,78]: nerve ring,
ventral and dorsal nerve cord, pharyngeal neurons, pharyngeal-
intestinal valve, intestinal-rectal valve, intestinal cell apical surface,
gonadal sheath, spermatheca, coelomocytes, cleavage furrow
membranes (newly formed) and the midbody of dividing embryos
(Figure 1G and 4F and data not shown). Analysis of the 1A2, 3H1,
and 5B1 monoclonal antibodies on western blots of wild type
animal lysates showed that they recognized a protein band of
100 kDa, in agreement with the predicted size of the protein
(Figure 2C). 5B1, renamed DYN1, has been submitted to the
DHSB.
APA-2
apa-2 (apt-4) encodes an adaptin for the alpha subunit of the
adaptor protein complex 2 (AP2) that is involved in endocytosis
[79]. A polyclonal antibody has been raised against the C-terminal
domain of C. elegans APA-2, amino acids 618–925 [80]. Six stable
hybridoma cell lines (1C8, 7D1, 7F5, 9C3, 10D1, and 11B11)
were produced and were of the isotype IgG1. All monoclonal
antibodies, except 1C8, immunostained whole mount animals with
a pattern that had previously been reported with the YFP-fusion
constructs and polyclonal antibody [80,81]: pharynx, intestine,
body wall muscle, hypodermis, seam cells and motor neurons
(Figure 1I and data not shown). Western blot analysis of wild type
N2 lysates revealed that the 11B11 monoclonal antibody
recognized protein bands of 102 kDa and 250 kDa (Figure 2C),
which is in good agreement with the predicted size of the protein,
104 kDa. The monoclonal antibody, 11B11, re-named APA2, has
been submitted to the DHSB.
Discussion
We have isolated a modest set of monoclonal antibodies against
a variety of C. elegans epitopes. The original goal of our project was
to isolate 60 monoclonals to epitopes of C. elegans, but we
succeeded in isolating only 21 monoclonals that met our criteria in
detecting endogenous antigen on whole mount in situs, and/or
C. elegans Monoclonals
PLoS ONE | www.plosone.org 9 April 2010 | Volume 5 | Issue 4 | e10161
western blots. We also isolated a monoclonal that recognizes a
non-C. elegans epitope, the His6-tag, which was used to purify many
of the fusion proteins. In addition, we isolated 20 monoclonals that
did not meet our criteria in detecting the endogenous antigen on
whole mounts and/or westerns. These 20 monoclonals were able
to detect the recombinant antigen by ELISA and westerns, but do
not: 1) detect the endogenous target protein on westerns and/or
whole mount in situs, 2) immunostain expected patterns as was
reported with the polyclonals and GFP-fusion constructs, and
instead stain unexpected structures, 3) detect an endogenous
protein band of an expected molecular weight on westerns and/or
detect multiple bands. A list and brief description of these 20
additional monoclonals is provided in the supplemental materials
section (Table S1; File S1). It should be noted that we did not
analyze a large set of fixation conditions in testing these
monoclonals. Thus, it may certainly be the case that some of
these would recognize endogenous, or over-expressed targets in C.
elegans using distinct fixation protocols or epitope recovery
techniques. Likewise, the protocols for using the monoclonals that
we have successfully used to detect antigen in situ may also not be
optimal. In addition, we have not optimized the transfer
conditions or transfer membranes for western analysis. Finally,
we have not examined transgenic lines that over express antigens
to test our panel of monoclonal lines.
Although we, or our colleagues [71], have performed experi-
ments to demonstrate that some of the monoclonal antibodies are
specific for the intended targets, we have not done so for all. There
are several reasons for this decision. First, in many cases the
appropriate tools are not available or have not been characterized.
For example, null mutant alleles are unavailable or poorly
characterized (e.g. knockout alleles which have not been
confirmed or backcrossed). In other cases, mutants are lethal
and balanced with markers that segregate aneuploids. In these
cases significant experimental effort would have been required to
develop or characterize the reagents needed to enable us to
document the specificity of the monoclonal lines. Such effort
would have come at the expense of our primary goal to create
monoclonals for the community. Second, specificity is condition
dependent. A monoclonal can be specific on whole mounts under
one fixation condition, but not under another. Hence, since most
researchers will be using these reagents in combination with other
immunological reagents they have developed, it is likely that the
conditions under which most of these tools will be used will differ
from the high throughput methanol fixation protocol we used.
Third, lack of specificity does not abrogate the potential use of a
monoclonal. For example, the RIM1 antibody described in this
paper is not specific for UNC-10 as it also recognizes signal in the
pharynx, but it is still useful for the analysis of neuromuscular
junctions in the ventral nerve cord. Thus, we opted to utilize our
limited financial resources to maximize the number of monoclonal
we could provide for the community, rather than to perform
specificity experiments that for all intensive purposes would need
to be repeated by scientists in their specific experimental systems.
The list of antigens that were chosen for this project was based
on a collaborative effort among various C. elegans researchers.
Input was solicited, and a list of 60 antigens for the production of
monoclonals was assembled. Nine research laboratories further
assisted us by their contribution of supplies towards our project in
the form of cDNA clones, expression constructs, fusion protein,
and/or polyclonal antibodies. All of these contributions, both in
supplies and recommendations, were valuable resources.
The design for the antigenic epitopes that were used in making
the monoclonal antibodies was based on the design of previously
published C. elegans polyclonal sera. In cases where there were no
previous polyclonals, the design of published mammalian poly-
clonals was taken into consideration in the design of the antigenic
epitope. Finally, in cases where a polyclonal did not exist or the
polyclonals reported in the literature were weak or not very
specific in immunolabeling as compared to the analogous GFP-
fusion constructs, we based our design of the epitope on the region
that we thought would give us the best antigenic response. The
logic for basing the epitopes on previous reported polyclonals were
that since they had already been shown to be both antigenic and
abundant, chances were that a successful monoclonal antibody
could be obtained. However, most monoclonals that we produced
were less effective at detecting targets in whole mount in situs than
the polyclonal sera that was raised against the same antigen.
Furthermore, many of the more robust antigens (as defined by the
antigenicity and quality of polyclonal sera) did not yield useful
monoclonal antibodies. One example of this was UNC-64,
syntaxin, which was a very robust antigen but failed to yield a
useful monoclonal in four fusion attempts. So, while the ability to
raise polyclonal sera is likely a reasonable prerequisite to use in
assessing whether to attempt to raise a monoclonal antibody, it is
certainly not a direct indicator of the likelihood of success.
A variable in our project as it was undertaken, was the decision
to inject with a His6-tagged fusion protein and to IV- or IP-
challenge with a GST-tagged fusion protein. This was done only if
the mouse polyclonal sera showed immunogenicity to both tagged
fusion proteins on ELISAs. This approach did seem to increase
our chances in obtaining successful monoclonal antibodies
(Examples are: SAX-7, DLG-1, LMN-1, DAO-5, HSP-60, CYP-
33E1, and SQV-8). However, there were cases where the mouse
polyclonals only recognized one of the two fusion proteins,
probably due to the intrinsic folding of the protein and exposure of
the available antigenic epitope to the antibody. We believe that
our chances in obtaining more successful monoclonal antibodies
would have been increased if we had made even more fusion
proteins to a variety of tags, both C- and N-terminus.
In conclusion, we present a set of monoclonal antibodies that we
believe will be useful tools for the scientific community. These
monoclonals can be used to label subcellular and cellular
components, as well as macromolecular complexes. They will
provide an unlimited source of antibody that cannot be exhausted
as polyclonals can, and will enable the elimination of some artifacts
that arise from immunolabeling using polyclonals that have been
made from different animals. These monoclonals are being made
available through the Developmental Studies Hybridoma Bank
(DHSB).
Materials and Methods
Construction of expression plasmids
Fusion constructs were made from restriction enzyme digested
purified PCR products that were amplified from C. elegans cDNA
made from total RNA that was reverse transcribed using an oligo-
dT or a random primer from a mixed-stage population of wild
type N2 worms. The unc-10 and rab-3 fusion constructs were made
from C. elegans cDNA clones obtained from Yuji Kohara. Details of
all constructs made are available in File S2.
Expression and Purification of Fusion Proteins
Fusion constructs were transformed into competent BL21 (DE3)
cells (Invitrogen) and grown overnight at 37uC in Luria Broth (LB)
supplemented with the appropriate antibiotic (100 mg/ml of
ampicillin, 20 mg/ml of choramphenicol, or 30 mg/ml of kana-
mycin. The cells were diluted 100 times in fresh pre-warmed
media, and grown to an OD600 = 0.6–0.7. Isopropyl b-D-
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thiogalactoside (IPTG) was added to 1 mM to induce expression
of the fusion protein and the cultures was incubated overnight at
room temperature.
His6 fusion proteins were batch purified on Nickel-nitrilotria-
cetic acid agarose (Qiagen, Valencia, CA) according to the
manufacturer’s protocols. The proteins were purified either in 8 M
urea and renatured by dialysis against PBS (SNB-1, DLG-1, CAV-
1, HCP-4, TAC-1, SAX-7, ERM-1, LMP-1, HMR-1, DAO-5,
ORC-2, PAS-7, CYP-33E1, HSP-60, SQV-8, LET-413) or were
purified under native conditions (UNC-10, SNB-1, APA-2, RME-
1, and LMN-1) with modified buffers and dialyzed against PBS
[82].
GST fusion proteins were purified with glutathione-agarose
beads (Sigma-Aldrich, St. Louis, MO), under native conditions
[83] and dialyzed into PBS [82]. The purity of the fractions was
verified by sodium dodecyl-sulfate polyacrylamide gel electropho-
resis (SDS-PAGE), and the concentration was determined by
Bradford assays.
Vertebrate Animals
Work with vertebrate animals (mice) in this study was
performed under the guidance of the Office of Laboratory Animal
Welfare (OLAW) in accordance with the Animal Welfare Act and
complies fully with the Guide for the Care and use of Laboratory
Animals (National Academic Press, 1996). Mice were housed and
cared for by veterinarians in the Washington University School of
Medicine Division of Comparative Medicine (DCM) Clinical
Sciences Research Building animal facility. Immunization and
blood drawing was performed by DCM staff. Mice were sacrificed
to obtain spleen cells using C02 inhalation, the recommend
method of euthanasia by the Washington University School of
Medicine Animal Studies Committee and a method approved by
the American Veterinary Medical Association Guidelines on
Euthanasia (June, 2007). The research involving the use of mice
described in this manuscript was approved by the Washington
University Animal Studies Committee (approval #20040341 and
#20070289). Washington University’s OLAW Animal Welfare
Assurance Number is A3381-01 and Washington University is
fully accredited by the AAALAC.
Immunization
Three female inbred BALB/c mice (Taconics, Hudson, NY), 5–
6 weeks of age, were immunized subcutaneously with a 1:1
emulsified mixture of recombinant fusion protein in phosphate-
buffered saline, pH 7.4 (PBS) at 50 mg per mouse using complete
Freund’s adjuvant (Sigma-Aldrich, St Louis, MO). Booster
immunizations were done subcutaneously with a 1:1 emulsified
mixture of the fusion protein in PBS at 50 mg per mouse using
incomplete Freund’s adjuvant (Sigma-Aldrich). The Washington
University Division of Comparative Medicine (DCM) animal
facility housed the animals and administered all injections. To
assess immunity and titer levels, both indirect ELISAs with the
fusion protein as the coating antigen and immunofluorescence
microscopy with fixed worms were performed. A final challenge
injection of the fusion protein at 37.5 mg in PBS was done
intravenously or intraperitoneally, 3–4 days prior to the fusion of
the splenic lymphocytes with the myeloma cells. Detailed
immunization schedules are provided in the supplemental
methods.
Cell Fusions
Mice were submitted to the Washington University School of
Medicine Hybridoma Center (WUHC, St. Louis, MO http://
pathology.wustl.edu/research/hybridoma.php), or to the Saint
Louis University (SLU) Custom Hybridoma Development Service
Facility (medschool.slu.edu/antibody/). WUHC performed all
fusions except for TAC-1 and SAX-7, which were performed by
the SLU Hybridoma Facility. The splenic lymphocytes were
isolated and fused with P3X63Ag8.653 myeloma cells [84].
Indirect ELISA and whole mount in situ screening was performed
to identify positives in the Nonet lab. Fusions that were performed
by the SLU Hybridoma Facility were screened by their facility on
immuno-dot blots with the fusion protein, prior to submitting the
hybridoma supernatants to the Nonet lab for further screening.
Cells that gave positive results were subcloned by limiting dilution
by the hybridoma facility. The first subclone and final expanded
supernatants were also screened on whole mount worms with
immunofluorescence microscopy. The isotypes of the monoclonal
antibodies were determined by ELISA with the following
commercial anti-isotype reagents: goat anti-mouse IgG1(c), IgG2a
(c), IgG2b (c), IgG3 (c), IgM (m), IgA (a) (Caltag Labs, Burlingame,
CA), rabbit anti-Mouse IgG, Kappa (USBiological, Swampscott,
MA), goat anti-mouse IgG (1+2a+2b+3) Fcc and goat anti-mouse
IgG (H+L) (Jackson ImmunoResearch, West Grove, PA).
Indirect ELISAs
Immulon 2HB 96-well flat bottom plates (VWR, Batavia, IL)
were coated overnight at 4uC with 100 ml per well of the fusion
protein in PBS at 1 ng/ml. The plates were washed with PBS and
blocked with 2% bovine serum albumin (BSA) in PBS for 1–
2 hours at RT. The plates were then washed twice with PBST
(PBS plus 0.05% Tween-20), and the supernatants were dispensed
into the wells at 50 mL/well and allowed to incubate for 1–2 hours
at room temperature. Three washes with PBST were performed,
followed by a 1-hour incubation with peroxidase-conjugated goat
anti-mouse IgG (H+L) or (Fcc) diluted in PBS. The plates were
washed three times with PBST and the detection reagent, ABTS
Peroxidase Substrate system (KPL), was applied. After incubation
at RT for 15 minutes, the absorbance was measured at 405 nm,
using a Perkin-Elmer plate reader.
To confirm specificity, all monoclonal antibodies were tested
against two different tagged versions of the fusion protein (e.g. a
His6-tagged protein and a GST tagged protein). In addition, they
were also tested against tag-only controls (His6 or GST) in ELISA
assays. The lone exception is the DYN-1 monoclonal antibody,
which was only tested on one tagged fusion protein and the tag
only control.
Immunocytochemistry
C. elegans were grown at 22.5uC on nematode growth media
(NGM) as described previously [85]. N2 wild type, lmp-1(nr2045)
[67], unc-10(md1117) [17], and snb-1(md247) [12] strains were used
in the study.
Two fixation conditions were used for the whole-mount
immunohistochemistry: Bouin’s [86] and methanol/acetone. For
the methanol/acetone fix, tubes of frozen worms (washed off of
large NGM plates) were thawed on ice and incubated in 2 volumes
of cold methanol at 4uC for 10 minutes, sonicated on ice with a tip
sonicator two times for 5 seconds each at maximal setting to break
open the worms. The tube was incubated on ice for 10 minutes
and spun down briefly in a microcentrifuge. The supernatant was
aspirated and 2 volumes of 220uC acetone were added to the
pellet. The worms were incubated on ice for 10 minutes and spun
down briefly in a microcentrifuge. The supernatant was removed
and 2 volumes of AbA (PBS + 0.05% Tween-20 + 0.5% BSA) were
added to the pellet. The worms were then incubated with rolling
agitation at RT for 30 minutes and spun down in a microcen-
trifuge. The supernatant was aspirated and two volumes of AbA +
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20% glycerol was added to the pellet. The worms were then
aliquoted and flash frozen in liquid N2 and stored at 280uC until
needed.
For immunostaining, fixed worms were incubated in BLOCK
[2% BSA + 2% gelatin+ 2% powdered milk (Carnation) +0.05%
Tween-20 in PBS] for 1–2 hours. The worms were washed three
times in PBST (PBS +0.1% Tween20), and incubated overnight at
4uC with a 1:10 dilution of the hybridoma tissue culture
supernatant in BLOCK. Worms were washed three times in
PBST and incubated for 1 hour with the secondary antibody
diluted in BLOCK. The secondary antibodies used to visualize the
binding pattern of the primary antibodies were goat anti-mouse
IgG Alexa FluorH 488 or 568 (Invitrogen, Carlsbad, CA) at a
1:2000 dilution. Gonads and intestines were fixed and stained as
previously described [87].
Samples were examined on a Zeiss Akioskop equipped with an
X-CITE 120 mercury bulb (EXFO) and standard epifluorescence
filters. Images were captured using a Regita EXi cooled CCD
camera and viewed using the Open Lab software (Improvision,
PerkinElmer, Boston, MA). Image panels were assembled in
Photoshop. In some cases, the corners of rotated images were
colored to match the background. Additionally, other stained
material in the field of view was excised to simplify images and
replaced with background signal. Original images are available
upon request. Gonad and Intestine images were assembled as
previously described [87].
Western Analysis
Western analysis was performed as described [13]. Mixed-
staged animals were grown to near starvation and diluted 5 fold
with an isotonic sucrose: HEPES solution (0.36 M sucrose, 12 mM
HEPES, and protease inhibitors). The animals were sonicated for
10 seconds on ice, and then microcentrifuged for 15 minutes.
Lysates typically contained about 3 mg/ml protein, and 20–30 mg
was loaded onto a 15% SDS-PAGE gel and transferred to PVDF
(Osmonics, Minnetonka, MN) using the a semi-dry transfer
method using the manufacturer’s protocol (BioRad, Hercules,
CA). Hybridoma supernatants were diluted 1:10 in PBS, and the
secondary goat anti-mouse IgG (H+L) peroxidase conjugated
antibody (Jackson ImmunoResearch) was used at a 1:15,000
dilution. The ECL detection kit (GE Healthcare, Piscataway, NJ)
was used to detect the labeling of the antibodies.
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